Bifunctional fusion proteins of the human engineered antibody domain m36 with human soluble CD4 are potent inhibitors of diverse HIV-1 isolates
- 13 August 2010
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 88 (1) , 107-115
- https://doi.org/10.1016/j.antiviral.2010.08.004
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- sCD4-17b bifunctional protein: Extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolatesRetrovirology, 2010
- Evaluation of CD4-CD4i Antibody Architectures Yields Potent, Broadly Cross-Reactive Anti-Human Immunodeficiency Virus ReagentsJournal of Virology, 2010
- A large human domain antibody library combining heavy and light chain CDR3 diversityMolecular Immunology, 2009
- Human monoclonal antibodies and engineered antibody domains as HIV-1 entry inhibitorsCurrent Opinion in HIV and AIDS, 2009
- Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120Journal of Virology, 2008
- Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizersProceedings of the National Academy of Sciences, 2008
- Construction of a Large Phage-Displayed Human Antibody Domain Library with a Scaffold Based On a Newly Identified Highly Soluble, Stable Heavy Chain Variable DomainJournal of Molecular Biology, 2008
- Tyrosine Sulfation of Human Antibodies Contributes to Recognition of the CCR5 Binding Region of HIV-1 gp120Cell, 2003
- Neutralization of Human Immunodeficiency Virus Type 1 by sCD4-17b, a Single-Chain Chimeric Protein, Based on Sequential Interaction of gp120 with CD4 and CoreceptorJournal of Virology, 2003
- Characterization of CD4-Induced Epitopes on the HIV Type 1 gp120 Envelope Glycoprotein Recognized by Neutralizing Human Monoclonal AntibodiesAIDS Research and Human Retroviruses, 2002